ESSA Pharma, Inc. (EPIX): Net earnings per share growth forecast for next year

ESSA Pharma Inc (EPIX) - corporate logo

A strong driver for ESSA Pharma Inc. (EPIX) is its staff of experienced biochemists, whose R&D expertise influences expectations for the company's EPS growth next year. The 0.00 indicator expresses the state of the metric on the chart. The development of targeted methods to combat resistant prostate cancer creates a unique niche, while the use of external CMO platforms for substance production ensures the operational flexibility of the business model.

EPIX: ESSA Pharma Inc Expected net earnings per share growth next year 07/04/2022 - 10/25/2025

EPIX (ESSA Pharma): analytical breakdowns and indicator data

- share price and consensus valuation forecast:
Stock Price ESSA Pharma, Inc.|EPIX - Average Forecast Price
- stock exchange capitalization data:
Market Value ESSA Pharma|EPIX - Business Value
- company book value details:
Book Value per Share ESSA Pharma|EPIX - Total Stockholders' Equity|Market Value to Book Value Ratio essapharma.com|EPIX - Company Total Asset Base
- debt obligations and liquidity statistics:
Debt to Equity ESSA Pharma Inc.|EPIX - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Capital ESSA Pharma, Inc.|EPIX - Company Aggregate Debts|Debt to Book Value ESSA Pharma|EPIX - Company Long-Term Loans and Borrowings|Company Short-Term Debt ESSA Pharma|Quick Ratio essapharma.com
- earnings and valuation multiples information:
EPIX - Final Profit|Projected Future Earnings ESSA Pharma Inc.|EPIX - P/E Multiple|Future Price to Earnings ESSA Pharma, Inc.|EPIX - Growth-Adjusted Payback Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization ESSA Pharma|EPIX - Operating profit before deduction of amortization|Net earnings per share (EPS TTM) ESSA Pharma|EPIX - Net earnings per share (EPS TTM)|Year-over-year net earnings per share growth for the last 12 months essapharma.com|EPIX - Earnings per share increase in current year|Earnings growth forecast for next year ESSA Pharma Inc.
Basic company analysis:ESSA Pharma Inc.
Core merchandise of ESSA Pharma

To minimize the risk of entering at a local peak, investors must rely on fundamental consensus rather than market noise. The specific nature of ESSA Pharma Inc. (EPIX) and its outsourcing of clinical trials shifts the valuation focus from capital expenditures to the efficiency of R&D patents. The consensus EPS forecast for the coming year measures expected net income dynamics, allowing for the determination of the business's real growth potential beyond immediate price fluctuations.

Competitor analysis for ESSA Pharma Inc.

MRUS (Merus Corp) - Earnings growth forecast for next year|Expected net earnings per share growth next year Immutep Corp IMMP|Net earnings per share growth forecast for next year Anixa Biosciences, Inc. (ANIX)|atossatherapeutics.com - Projected earnings per share growth rate for next year|Earnings growth forecast for next year CNTX (Context Therapeutics Inc.)|Mersana Therapeutics Inc (MRSN) - Expected net earnings per share growth next year|BCTX - Net earnings per share growth forecast for next year|Consensus forecast of earnings per share growth for next year QT Imaging, Inc. QTI